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Trends in death certification rates from peptic ulcer between 1955 and 1989 have been analysed for 24 European
countries on the basis of age-specific and age-standardized rates, and a log-linear model to estimate the effects of age,
cohort of birth and period of death. For males, in all Western countries there were substantial declines in mortality. In
the late 1950s, the range of variation of the world standardized rates was between 4/100 000 in France and 17.8 in
Portugal. In the late 1980s, only Ireland had a rate over 5/100 000, and values for most Western countries ranged
between 2 and 4/100 000. The average fall in rates over the last three decades was 56%. Of this, a high proportion
(45%) was registered between 1975 and 1984. In Eastern Europe, no systematic change was observed until the early
1970s, but over the last 15 years peptic ulcer mortality declined by an average of 20%. In 1985-1989 the lowest rate was
4.5/100 000 in Bulgaria, and for all other countries peptic ulcer mortality ranged between 5 and 7.2/100 000. Peptic
ulcer mortality was substantially lower in females, and showed no appreciable modification in Western Europe, and
several increases in Eastern Europe until the mid 1970s. Thereafter, mortality declined by an overall 25% in the West
and 15% in the East. Earlier declines for males in Western Europe were chiefly related to a cohort effect, reflecting more
favourable risk factor exposure {such as diet, Helicobacter pylori or smoking) of subsequent generations. The
recent falls, in contrast, were mainly on a period of death basis indicating therapeutic advancements (including the
introduction of H2-receptor-antagonists in the mid-1970s) as the major determinant. These falls correspond to about
20 000 deaths from peptic ulcer avoided every year in the whole of Europe.
Peptic ulcer had become a major public health prob-
lem and a common cause of death by the middle of the
current century. The rates had been rising in most
developed countries during the first half of the
century.1'2
Thereafter, however, ulcer rates have started to
decline, mainly on a cohort of birth basis, i.e. starting
from younger generations.3"13 This trend pattern prob-
ably reflects favourable changes in exposure to risk
factors (such as diet, smoking and infectious agents) in
more recent generations.
Important downward trends in peptic ulcer mor-
tality were also observed from the late 1970s, following
the introduction of effective therapies (mainly
histamine-2(H2)-receptor-antagonists). These rate
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changes were, therefore, mainly on a period of death
basis, since these therapies favourably affected ulcer
mortality during the same calendar period for various
age groups.13"13
To understand further the underlying determinants
of peptic ulcer mortality trends, this article will sum-
marize changes in mortality in various European coun-
tries between the late 1950s and the mid 1970s (i.e.
before the introduction of effective therapies), and
thereafter, i.e. up to the late 1980s. The related impact
in terms of public health and estimated numbers of
avoided deaths will also be evaluated and discussed.
MATERIALS AND METHODS
Death certification numbers from peptic ulcer,
stratified for sex and 5-year age groups for 24 Euro-
pean countries (excluding a few small countries like
Iceland, Luxembourg, Malta, Liechtenstein etc.), were
derived from copies of the original computer tapes of
the World Health Organization (WHO) database.
During the calendar period considered (1955-1989),
four different revisions of the International Classifica-
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tion of Diseases (ICD)16"19 were used. Classification of
peptic ulcer deaths was recoded according to the Ninth
Revision of the ICD. Gastric ulcer (ICD 540 in the
Sixth and Seventh Revisions; ICD 531 in the Eighth
and Ninth) duodenal ulcer (ICD 541 in the Sixth and
Seventh Revisions; ICD 532 in the Eighth and Ninth),
gastrojejunal ulcer (ICD 542 in the Sixth and Seventh
Revisions; ICD 534 in the Eighth and Ninth), and
gastroduodenal ulcer (ICD 533 in the Eighth and Ninth
Revisions) were grouped together on account of dif-
ficulties in the interpretation of potential changes in
classification and death certification reliability.
Estimates of the resident population, generally
based on official censuses, were obtained from the
same WHO databank. From the matrices of certified
deaths and resident populations, age-standardized
rates (on the World standard population) were com-
puted. Besides overall age-adjusted rates, truncated
ones at age 35-64 were chosen for presentation. Trun-
cated rates are of interest for at least two reasons;
since: i) they provide information specifically on
trends in middle age, and ii) death certification in the
elderly is generally less reliable, and may therefore in-
troduce spurious trends in rates.
In a few countries, data were missing for part of one
or more calendar periods. When a single year was
missing within a quinquennium, numerators and
denominators were interpolated linearly for the
previous and subsequent calendar years. No extrapola-
tion was made for missing data at the beginning or the
end of the calendar period considered, or when data
on one or more quinquennia were not available.
Further, an age, period and cohort model with
arbitrary constraints on the parameters was applied to
the matrices of age-specific rates between 25 and 79
years.
For the purpose of model fitting deaths among those
aged over 79 were not considered, since death certifica-
tion is known to be less accurate in older age groups.
We chose 25 as the lower age limit, to reduce the
problem of random variation due to small numbers.
Cohorts were defined according to the central year of
birth. For instance, the earliest possible cohort con-
sidered (the 1880 cohort) relates to people aged 75-79
who died in the quinquennium 19554959 : they could
have been born in any of 10 years from 1875 to 1885
inclusive.
The method was derived from that proposed by
Osmond and Gardner,20 and has been previously
described.21 Briefly, from the matrices of age-specific
death rates for each 5-year calendar period and age
group, the effect of age, birth cohort and period of
death was evaluated through a log-linear Poisson
model, fitted using the Generalized Linear Interactive
Modelling (GLIM) procedure22 with appropriate user-
supplied macros.21 In simplified terms, the estimates
presented are derived from the model including the
three factors (age/cohort/period) which minimizes the
sum of the Euclidean distances from the three possible
two-factor models (age/period; age/cohort; period/
cohort). Cohort and period of death values were
averaged to unity; the age values are interpretable in
terms of mean age-specific death rates in the period
considered. Cohort values related to earlier and more
recent periods are based on fewer age-specific rates
(e.g. only one for the 1885 cohort, two for 1890, etc.)
and hence are less stable and reliable than central ones.
RESULTS
Table 1 gives the overall death certification rates from
peptic ulcer in males for three selected calendar quin-
quennia, 1955-1959, 1970-1974 and 1985-1989 in 16
Western European and eight Eastern European coun-
tries. In all Western countries there were substantial
declines in mortality. In the late 1950s, the range of
variation of overall standardized rates was between
4.0/100 000 in France and 17.8/100 000 in Portugal.
In the early 1970s, the lowest rate was in Norway
(3.8/100 000) and the highest again in Portugal
(10.6/100 000). In the late 1980s, only Ireland had a
rate over 5.0/100 000, and values for most Western
European countries were 2-4/100 000. The average
fall in rates over the last three decades was 56%. Of
this, the largest part (45%) was registered between
1975 and 1988.
In Eastern Europe, peptic ulcer mortality in
1955-1959 ranged between 6.5/1OOOO0 in
Czechoslovakia and 9.9/100 000 in Romania. No
systematic change was observed until the early 1970s,
but over the last 15 years rates declined by an average
of 20%. For 1985-1989 the lowest rate (for Bulgaria)
was 4.5/100 000, and for all other countries male
peptic ulcer mortality was 5-7.2/100 000.
The pattern was similar, but the proportional falls
were larger, when only truncated rates for 35-64 year
olds were considered (Table 2). In Western Europe
appreciable declines were already observed in the
earlier calendar period, but these became more pro-
nounced over recent years. The overall average fall
between 1955 and 1989 was 74%, and most of this fall
(64%) was registered after 1975. In Eastern Europe
there was no appreciable trend in earlier calendar
periods, but peptic ulcer mortality declined by
approximately 25% from 1975 onwards.
Peptic ulcer mortality was substantially lower in
females (Table 3). In 1955-1959 the range of variation
TABLE I Overall death certification rates per 100 000 males from peptic ulcer in selected European countries, 1955-19S9
oo
Country
Western Europe
Austria
Belgium
Denmark
Finland
France
Germany, FRG
Greece
Ireland
Italy
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
UK
Eastern Europe
Bulgaria
Czechoslovakia
Germany, GDR
Hungary
Poland
Romania
USSR
Yugoslavia
Mortality
1955-1959
8.7
5.7
6.6
8.9
4.0
8.1
7.5
10.0
8.9
7.0
4.4
17.8
8.6
8.1
7.8
12.4
6.5
-
7.8
7.7
9.9
-
_
rates per 100 000 males
1970-1974
8.4
4.7
5.8
4.8
4.3
7.3
4.2
7.8
9.3
4.6
3.8
10.6
8.2
7.8
5.6
7.1
6.4
6.9
9.2
9.3
8.5
5.0
-
7.0
in
1985-1989
4.4
2.4
4.6
4.2
2.8
3.1
2.1
5.4
3.2
2.3
3.3
3.4
2.8
3.4
2.4
4.9
4.5
5.6
6.3
7.2
6.0
5.2
5.7
6.5
1% change
1985-1989 vs.
1955-1959
-49
-58
-30
-53
-30
H52
-72
-46
-64
-67
-25
-81
-67
-58
-69
-60
.
-14
-
-8
-22
-47
-
_
in rates
1985-1989 vs.
1970-1974
-48
-49
-21
-13
-35
-58
-50
-31
-66
-50
-13
-68
-66
-56
-57
-31
-30
-19
-32
-23
-29
+ 4
-
-7
>
5
>
o
o
•n
m
~oa
m2
5
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TABLE 2 Truncated 35-64 year death certification rates per 100 000 mala from peptic ulcer in selected European countries, 1955-1959 to
1985-1989
Country
Western Europe
Austria
Belgium
Denmark
Finland
France
Germany, FRG
Greece
Ireland
Italy
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
UK
Eastern Europe
Bulgaria
Czechoslovakia
Germany, GDR
Hungary
Poland
Romania
USSR
Yugoslavia
Mortality rates per 100 000 males in
1955-1959
13.7
9.8
10.0
15.5
6.7
16.0
9.8
17.7
18.0
10.5
7.3
31.8
14.8
11.9
10.6
15.8
10.7
-
13.3
14.1
18.4
_
_
1970-1974
10.5
5.3
5.9
6.5
5.8
10.9
4.0
8.1
13.3
5.1
4.6
15.1
11.0
6.9
6.3
7.1
8.8
9.6
12.3
12.9
12.7
9.3
_
10.9
1985-1989
4.4
2.0
3.4
4.4
2.5
2.9
1.8
4.2
2.7
1.6
2.4
3.5
2.4
2.8
1.7
4.0
6.6
8.3
8.2
11.0
8.5
9.4
10.4
6.9
ft change
1985-1989 vs.
1955-1959
-68
-80
-66
-72
-63
-82
-82
-76
-85
-85
-67
-89
-84
-76
-84
-75
-22
-
-17
-40
-49
_
_
in rates
1985-1989 vs.
1970-1974
-58
-62
-42
-32
-57
-73
-55
-48
-80
-69
^t8
-77
-78
-59
-73
-44
-25
-14
-33
-15
-33
+ 1
_
-37
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m
n
c
Q
O
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TABLE 3 Overall death certification rates per 100 OOO females from peptic ulcer in selected European countries, 1955-1959 to 1985-1989
8
Country
Western Europe
Austria
Belgium
Denmark
Finland
France
Germany, FRG
Greece
Ireland
Italy
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
UK
Eastern Europe
Bulgaria
Czechoslovakia
Germany, GDR
Hungary
Poland
Romania
USSR
Yugoslavia
Mortality rates per 100 000
1935-1959
3.0
1.0
2.4
1.8
0.8
1.5
2.4
3.1
1.6
2.1
1.4
3.2
1.8
3.1
3.0
3.5
1.7
1.7
-
1.9
1.8
2.3
-
_
1970-1974
3.1
1.7
2.7
2.0
1.1
2.1
1.5
3.4
1.9
1.9
1.5
2.5
1.9
3.5
2.4
2.8
1.9
2.2
2.9
3.3
2.2
1.3
-
2.4
females in
1985-1989
2.4
1.2
3.2
2.0
1.1
1.6
0.9
2.5
1.1
1.3
1.6
1.2
1.0
1.8
1.4
3.1
1.4
2.0
2.5
3.1
2.0
1.3
1.2
1.9
*h change in
1985-1989 vs.
1955-1959
-20
+ 20
+ 33
+ 11
+ 38
+ 7
-«3
-19
-31
-38
+ 14
-63
-44
-42
-53
-11
-18
+ 18
-
+ 63
+ 11
^15
-
_
rates
1985-1989 vi.
1970-1974
-23
-29
+ 19
-
-
-24
t^o
-26
-42
-32
+ 7
-52
-47
-49
-42
+ 11
-26
-9
-14
-«
-9
-
-
-21
o
o
>
r-
O
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m
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was between 0.8/100 000 in France and 3.5/100 000 in
the UK. No appreciable modification was observed
until the early 1970s, but from 1975 to 1989 overall
peptic ulcer rates declined by approximately 25%. In
Eastern Europe the rates in the 1950s were comparable
(i.e. between 1.7/100 000 in Bulgaria and Czechoslo-
vakia and 2.3/100 000 in Romania). Most countries
showed upward trends between 1955 and 1974,
followed by subsequent declines. Thus, rates in the late
1980s were about 15% lower than those registered
three decades earlier.
Systematic differences between Western and Eastern
Europe were also evident for females on inspection of
truncated rates (35-64 years, Table 4). Peptic ulcer
mortality rates in middle aged women started from
comparable values in the late 1950s for the two areas
of the continent (i.e. a round 2-3/100 000 in most
countries), but the decline was much greater in
Western Europe, averaging 63% between 1955 and
1989, and 50% over the last 15 years alone. In Eastern
Europe, the decline was only about 20%.
Figure 1 summarizes the range of variation in peptic
ulcer mortality in various European countries over the
last calendar period (1985-1989). Figure 2 gives trends
in age-standardized (all age and truncated) rates in the
four largest Western and the four largest Eastern
European countries.
Figure 3 gives the estimates from the age, period and
cohort model for the same countries, excluding
Yugoslavia (where data for 1955-1959 were not
available).
In the four Western countries the peak in the cohort
effect for males was registered between 1890 in the UK
and 1900-1910 in France, Germany and Italy, and the
decline in rates for the most recent cohorts (born in
1960) was substantial, with a value of 0.20-0.03 (i.e.
with a reduction from 80% to over 95%) as compared
to the weighted average of all cohort values. The fall in
cohort values started later in Eastern European coun-
tries, particularly in Hungary, and the value for the
youngest generation ranged between 0.4 (in Czecho-
slovakia and Poland) and 0.55 in Hungary, i.e. the
TABLE 4 Truncated 35-64 years death certification rates per 100 000 females from ptptk ulcer in selected European countries, 1955-1959 to
1985-1989
Country
Western Europe
Austria
Belgium
Denmark
Finland
France
Germany, FRG
Greece
Ireland
Italy
Netherlands
Norway
Portugal
Spain
Sweden
Switzerland
UK
Eastern Europe
Bulgaria
Czechoslovakia
Germany, GDR
Hungary
Poland
Romania
USSR
Yugoslavia
Mortality
1955-1959
3.3
1.1
3.0
2.2
0.8
2.1
1.7
4.6
2.2
2.0
1.6
5.6
2.3
3.4
2.8
3.4
1.8
2.3
-
2.4
3.2
3.2
-
-
rates per 100 000
1970-1974
2.9
1.2
2.5
1.8
0.9
2.3
0.9
3.6
1.9
1.3
1.2
2.5
1.6
2.4
1.6
2.4
2.0
2.1
3.1
3.4
2.8
2.1
-
3.0
females in
1985-1989
1.7
0.3
2.7
1.3
0.6
1.0
0.5
1.1
0.6
0.6
0.7
0.9
0.4
0.9
0.6
2.1
1.2
2.1
2.5
3.2
2.3
1.8
1.6
1.8
% change in rates
1985-1989 vs.
1955-1959
-48
-73
-10
^11
-25
-52
-71
-76
-73
-70
-56
-84
-83
-74
-79
-38
-33
- 9
-
+ 33
-28
-44
-
-
1985-1989 vs.
1970-1974
-41
-75
+ 8
-28
-33
-57
-44
-69
-68
-54
-42
-64
-75
-63
-63
-13
^»0
-
-19
-6
-18
-14
-
-40
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FIGURE 1 Age-standardized (world standard) peptic ulcer mortality rates In various European countries, 1985-1989
estimated decline was 45-60%. In the UK, the period
effect showed a steady decline, but in all other coun-
tries appreciable falls only became evident from the
mid-1970s. The declines in period values were earlier
and steeper in Western than in Eastern Europe.
Among females, the peak values for cohort effects
were observed between 1910 and 1930 in the four
Western European countries considered, and the
declines were appreciable (from 50% in France to over
80% in other countries). Of the three Eastern Euro-
pean countries, only Poland showed some fall in the
cohort effect, starting from 1940 onwards. No con-
siderable change was observed in Czechoslovakia, (ex-
cept in the last cohort) and cohort values increased in
Hungary. As in males, the estimated relative decline in
period of death values over the last one or two decades
was greater in Western than in Eastern Europe.
DISCUSSION
This overview of trends in peptic ulcer mortality in
various European countries documents and quantifies
the major declines observed in peptic ulcer mortality
during the last four decades.
A possible explanation for these declines in mor-
tality rates could be an artefact resulting from changes
in coding and diagnostic accuracy. These analyses and
inferences are, in fact, based on official death certifica-
tions which, to a variable extent, are subject to problems
of reliability and validity. To reduce these problems,
we pooled all deaths attributed to peptic ulcer (gastric,
duodenal, and unspecified). However, changes in
accuracy of diagnosis and certification in various
countries are unlikely to explain, largely or wholly,
such a consistent and substantial fall in mortality rates.
Substantial differences were evident in the two sexes
and between Western and Eastern Europe, since for
males in most Western European countries peptic ulcer
mortality was already declining between the 1950s and
the 1970s, and this decline was greater in the last
decade. Rates were stable—or moving upwards—for
males in Eastern Europe up to the late 1970s and some
decline was only evident during the last decade. For
females, ulcer mortality between the 1950s and the
mid-1970s did not show appreciable and systematic
changes in any area of the continent, but recent
declines were greater in Western than in Eastern
Europe.
Earlier declines for males in Western countries were
chiefly related to a cohort effect, since rates had
started to decline from younger generations.6"9'15 This
probably reflects more favourable patterns of ex-
posure to risk factors for ulcer (such as diet,
Helicobacter pylori or other infectious agents, and
smoking) in each subsequent generation.2-9 These
downward trends were not observed in Eastern
European countries, whose fall in cohort values were
later and more moderate, and whose rates did not
appreciably change until the mid-1970s for males, and,
if anything, increased for females, indicating, that, in
these countries, there was no earlier favourable
modification in risk factor exposure. The recent falls,
in contrast, were mainly on a period of death basis.
This indicates that the main underlying determinant is
related to therapeutic advancements, which affected
in a similar calendar period and to a comparable extent
subjects of different ages. The introduction of
H2-receptor-antagonists in the late 1970s is probably
the main determinant of the recent substantial declines
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Trends in age-standardized (world standard) mortality rates from peptic ulcer in selected European
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FIGURE 3 Age, cohort of birth and period of death effects from peptic ulcer mortality in selected European countries, derived from a log-
linear age-period and cohort model.21
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FIGURE 3 Continued.
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in ulcer mortality, producing a reduction in the
complications of the disease (perforated ulcer and
haemorrhage), as well as of the consequent surgical
procedures and related mortality.n.'3-".24 Other fac-
tors, however, may have had a favourable impact,
including better surgical techniques, broad spectrum
antibiotics, and therapeutic endoscopy.2-23-26
The impact of newer therapies on ulcer mortality
was, however, heterogenous in various European
countries. In Western Europe, the average fall in ulcer
mortality over the last decade approached 50% among
males of all ages and 65% in middle age, while the cor-
responding gains in Eastern Europe were only 20%
and 25%, and in females the declines were also
appreciably lower in Eastern Europe.
Overall, about 20 000 deaths per year were avoided
in the whole of Europe in the late 1980s. This major
advance, however, cannot totally eclipse a second
major message emerging from this report, i.e. that
there is ample scope for further improvement in ulcer
treatment in Europe through a more widespread and
rational application of available treatments. Assuming
that the same rate of decline reported in Western
Europe could be extended to Eastern countries, a
further 5000 deaths per year could have been avoided.
Even in Western Europe some moderate, but con-
tinuing decline in ulcer death rates was still apparent in
recent years. This would suggest that further improve-
ment is still possible following further therapeutic
development27 and/or more rational use of drugs in-
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troduced in the 1970s. Assuming that these trends con-
tinue in future, it is therefore possible that peptic ulcer
will become an avoidable cause of death.
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